DWA
CMRX

Dorsey Wright & Associates’s Chimerix, Inc. CMRX Stock Holding History

Dorsey Wright & Associates’s Portfolio CMRX Stock Details CMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,801
Closed -$46.3K – 361
2021
Q1 		$46.3K Buy
+4,801
New +$44.1K 0.54% 64

Other funds holding CMRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dorsey Wright & Associates's CMRX Position: Q2 2021 in Review

Dorsey Wright & Associates sold out of Chimerix, Inc. (CMRX) in Q2 2021, closing a stake of 4,801 shares — an estimated $46.3K sold.

Dorsey Wright & Associates first reported a position in CMRX in Q1 2021 and held it in 1 quarter. The position peaked at $46.3K in Q1 2021. 109 funds tracked by Wall St. Rank hold CMRX as of Q2 2021.

  • Dorsey Wright & Associates reported no remaining Chimerix, Inc. position as of Q2 2021 after selling out during the quarter.
  • Dorsey Wright & Associates sold 4,801 Chimerix, Inc. shares in Q2 2021, an estimated $46.3K.
  • Dorsey Wright & Associates first reported a position in Chimerix, Inc. in Q1 2021 and held it in 1 quarter.
  • Dorsey Wright & Associates's Chimerix, Inc. position peaked at $46.3K in Q1 2021.
  • 109 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q2 2021.

Based on Dorsey Wright & Associates's 13F filing for Q2 2021, filed 23 Jul 2021.